Overall rank by patents
#27,749
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 2 technology areas, active 2016–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B63B (SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING).
The verdict
Vivere holds 10 US patents across 2 technology areas, rank #27,749 of 50,000 tracked assignees.
Vivere Ltd. has been granted 10 US utility patents between 2016 and 2024, placing Vivere Ltd. at rank #27,749 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 2.8 claims per patent with primary concentration in B63B (SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING). As a Foreign Corporation, Vivere Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Vivere sits between Viking TECH Corporation (10 patents, rank #27,745) and VSI, Llc (10 patents, rank #27,753) - the closest US assignees by grant volume. The composite Innovation Score of 17.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 6 in the 2015–2019 window, a -33% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Vivere Ltd.'s 2.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Vivere Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
VIKING TECH CORPORATION
10 patents
VISHAY SPRAGUE, INC.
10 patents
VISMUNDA SRL
10 patents
VISTAGEN THERAPUETICS, INC.
10 patents
VOESTALPINE VAE GMBH
10 patents
VOTI INC.
10 patents
VOXY, INC
10 patents
VSI, LLC
10 patents
VIVERE LTD.
10 patents
What this shows Vivere holds 10 patents at rank #27,749, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,749 in granted patent volume.
Other assignees with the most granted patents in Vivere's primary technology class.
Vivere's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
17 Top 96% higher than 4% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 20.0% |
| 2017 | 3 | 30.0% |
| 2018 | 1 | 10.0% |
| 2020 | 2 | 20.0% |
| 2021 | 1 | 10.0% |
| 2024 | 1 | 10.0% |
Top 2 of 2 technology areas
Overall rank by patents
#27,749
Across all tracked assignees
17.2 out of 100
How to use this portfolio
Vivere's 10 grants land it in the top 96% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.